Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Clear Labs, NRichDx, Qiagen, More

Clear Labs Clear Dx Whole-Genome Sequencing Kit for SARS-CoV-2

Clear Labs has launched the Clear Dx whole-genome sequencing solution for enhanced screening and genomic surveillance of SARS-CoV-2.

Intended for use with samples that have already tested positive for SARS-CoV-2 by another method, the automated next-generation sequencing assay provides the complete RNA genome of the virus in less than 24 hours with approximately 30 minutes of hands-on time. The kit is for research use only.


NRichDx Revolution Sample Prep Semi-Automated Workflow

NRichDx has launched its semi-automated Revolution Sample Prep Workflow, powered by Eppendorf's epMotion 5073 instrument, for extraction of cell-free and circulating tumor DNA from a wide range of input sample volumes. The firm has designed the workflow to increase yield, sensitivity, and throughput by delivering more target cfDNA and ctDNA for molecular assays with increased automation and reduced hands-on technician time. The workflow allows for extraction from batches of eight to 24 samples in as little as three hours.


Qiagen QiAcuity One-Step Viral RT-PCR Kit for Wastewater Testing

Qiagen has launched a dedicated RT-PCR kit for SARS-CoV-2 wastewater testing on the company's QiAcuity Digital PCR platform. QiAcuity precisely quantifies minimal quantities of DNA and RNA, making it ideal for research tests for viruses, bacteria, or genetic disorders. The platform is available in a one-plate, four-plate, and eight-plate version, all of which feature flexible sample throughput and the ability to simultaneously detect up to five target sequences. This enables the QiAcuity Eight, for instance, to process up to 1,248 samples in one working day, Qiagen said.


For more new products and services, please visit the New Products page on our website.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.